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 Abstract 
Frequency of macrolide to and clindamycin inducible resistance 
among Staphylococcus aureus isolates collected from clinical 
specimens in teaching hospitals affiliated to Ardabil University 
medical science 2017. 
Background & Objectives: Staphylococcus aureus (SA) is one of the most common 
agents responsible for human infection. This bacterium produces armamentarium of virulence 
determinants that promote its infections. Treatment of MDR SA infections are major medical 
concern. Macrolide-lincosamide-streptogramin (MLS) antibiotics are frequently used in 
treatment of staphylococcal infections. In this study MLS resistance phenotypes, virulence 
factors profiles, spa types and clonal relatedness of SA isolated from clinical specimens in 
Ardabil, Iran were investigated.  
Methods: A total of 118 SA isolates (42.4% MSSA and 57.6% MRSA) were collected 
from clinical specimens in four teaching hospitals in 2017 and 2018. The SA was identified 
using standard microbiological and molecular methods.  MLS resistance was determined by 
disk diffusion tests and inducible clindamycin resistance was detected using D test. The 
Minimum Inhibitory Concentrations (MIC) of erythromycin and vancomycin were 
determined using agar dilution method. The genes encoding resistance to MLS antibiotics 
and virulence determinants were detected using PCR testing. Spa type of macrolide resistant 
SA isolates were examined using PCR and sequencing. The genetic relatedness of SA isolates 
was determined using ERIC-PCR method.  
Results: Totally, 38 (30.5%) and 58 (49.2%) isolates were resistant against erythromycin 
and clindamycin antibiotics. No vancomycin resistant SA was detected. From 58 
erythromycin resistant SA 29 (50%), 17 (29.3%) and 12 (20.7%) isolates were identified as 
cMLSB, iMLSB and MS phenotypes respectively. iMLSB phenotype was significantly higher 
in MSSA 11 (55%) versus MRSA 5(13.2%) isolates (P < 0.05). Of the genes examined for 
erythromycin resistance, ermC 42 (72.4%) was the most frequently identified gene followed 
by ermA 35 (60.3%) and ermB 35 (60.3%), ermTR 30 (51.7%) and msrA 9 (15.5%). 
According to the distribution of the resistance genes among the isolates,19 resistance profile 
were identified.  The ermA+ermB+ermC 7 (12.1%) was the most prevalent profile identified. 
Of the virulence encoding genes, hla 110 (93.2%) was the most frequently identified gene 
followed by hld 88 (74.5%), sea 83 (70.3%), LukS PV  38 (32.2%), tst 35 (29.6%), seb 20 
(17%), sed 10 (8.5%) and eta 10(8.5%), sec 7(5.9%) and etb 5(4.2%). Based on distribution 
of virulence genes, 30 virulence profiles were detected. The genes including hla + hld + sea + 
tst 7 (12.1%) was most prevalent virulence profile identified.  MRSA isolates showed 
versatile virulence profiles compared to   MSSA. spa-typing results divided the isolates into 
t030 types with t310 as the most common one. A novel spa type (IDs:WGJQQ ) was 
identified in this study for the first time. According to ERIC-PCR results the 58 erythromycin 
resistant isolates fell into 41 clusters. There was no significant clonal relatedness between the 
erythromycin resistant isolates.  
Conclusion: These findings revealed, significant portion of SA isolates were resistant 
against MLS antibiotics and carried multiple genes encoding resistance and virulence genes 
posing a potential therapeutic concern. Emergence of iMLSB phenotype highlights the need 
for routinely applying D test in microbiology laboratories. More significantly a novel spa 
type (IDs:WGJQQ) was reported in this study for the first time. 
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